product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Ly-6C Antibody (HK1.4) [DyLight 650]
catalog :
NBP1-28046C
quantity :
0.25 ml
price :
509 USD
clonality :
monoclonal
host :
rat
conjugate :
DyLight 650
clone name :
HK1.4
reactivity :
mouse
application :
flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP1-28046C
SKU :
NBP1-28046C
product name :
Ly-6C Antibody (HK1.4) [DyLight 650]
sizes available :
0.25 ml
description :
The Ly-6C Antibody (HK1.4) [DyLight 650] from NBP1-28046C is a 6.3e-05 antibody to . This antibody reacts with mouse.
target :
Ly-6C
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
HK1.4
conjugate :
DyLight 650
dilution :
Flow Cytometry
host :
Rat
immunogen :
L3 cloned CTL cells
isotype :
IgG2c Kappa
purity :
Protein A or G purified
species :
Mouse
specificity :
Murine Ly-6C, Mr 18 kDa
gene symbol :
Ly6c1
applications :
Flow Cytometry
USD :
509 USD
alt names :
Ly 6c, Ly6c protein, Lymphocyte antigen 6 complex, Lymphocyte antigen 6 complex locus C, Lymphocyte antigen 6C, Lymphocyte antigen Ly 6C
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- CD4 Antibody (V46P5B10*D5) [Janelia Fluor® 525] | NBP2-50140JF525
- KRAS Antibody (D113) [Alexa Fluor® 700] - Mutant | NBP3-43583AF700
- Ly-6C Antibody (HK1.4) [Allophycocyanin] | NBP1-28046APC
- Ly-6C Antibody (HK1.4) [Alexa Fluor® 750] | NBP1-28046AF750
- CD4 Antibody (V46P5B10*D5) [DyLight 755] | NBP2-50140IR
questions and comments
